The industry's value stood at US$ 55.5 million in 2022, and it is forecasted to grow at a Compound Annual Growth Rate (CAGR) of 12.2% from 2023 to 2031, reaching US$ 160.7 million by the end of 2031.

The global intragastric balloons market is experiencing a surge, primarily fueled by the escalating prevalence of obesity worldwide. Over the past few years, there has been a noticeable uptick in the adoption of intragastric balloons among both patients and physicians. This trend is attributed to their clinically-proven efficacy coupled with minimal risk, pain, and recovery time, which are pivotal factors propelling market expansion.

Access Sample PDF: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=26006&utm_source=organic&utm_campaign=MansiR_organic

Moreover, the growing demand for minimally invasive weight-loss therapies is anticipated to further bolster the global intragastric balloons industry throughout the forecast period. As individuals increasingly prioritize less invasive treatment options, the market for intragastric balloons is poised for substantial growth in the coming years.

Market Overview:

Intragastric balloons, also referred to as stomach balloons or gastric balloons, are medical devices utilized for inducing weight loss. These devices are temporarily inserted into the stomach and function by occupying space within it, thereby prompting the patient to feel full sooner during meals. This mechanism aids in reducing food intake, facilitating weight management.

Typically implanted endoscopically, intragastric balloons are filled with saline solution to maintain inflation within the stomach for a predetermined duration, commonly around six months. Some variations include self-deflating models. Upon completion of the intended period, these balloons are either removed endoscopically or expelled from the body passively. Clinical research has demonstrated that intragastric balloons, in conjunction with lifestyle modifications, can assist patients in shedding 15% to 25% of their body weight.

Key Players:

Apollo Endosurgery, Inc., ReShape Lifesciences, Inc., Spatz FGIA, Inc., Allurion S.a.s., ENDALIS, Helioscopie, LEXEL S.R.L., and CSC MEDSIL

Market Segmentation:

• Duration
  • <6 Months
  • 6 Months
  • >6 Months

• Type
  • Fluid-filled Balloons
  • Gas-filled Balloons

• Administration
  • Endoscopy
  • Swallowable

• End-user
  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics

Increase in Demand for Minimally Invasive Weight-loss Therapies

In recent years, there has been a notable surge in demand for weight loss methods that are minimally invasive and pose low risk. As more individuals seek effective weight management solutions without extensive lifestyle changes or invasive surgeries, the intragastric balloons industry has experienced significant growth. This trend reflects a broader shift towards less disruptive approaches to weight control.

Intragastric balloons offer an outpatient weight loss procedure characterized by rapid recovery times and minimal post-operative restrictions. Compared to more invasive bariatric surgeries, which often require longer hospital stays and complex aftercare, balloons present a less intrusive alternative.

The appeal of balloon treatment as a primary option for overweight individuals lies in its low procedural risk and simplicity. With the introduction of newer self-expandable models that eliminate the need for endoscopic removal, demand for these devices has increased further. Moreover, rising awareness of obesity-related health risks has spurred interest in non-surgical weight loss interventions, positioning balloons as a clinically verified solution either as a preliminary step or an alternative to more invasive procedures.

Key Developments in Global Intragastric Balloons Market

• In October 2023, Spatz Medical received FDA approval for its Spatz3 Gastric Balloon, the first adjustable gastric balloon system. The Spatz3 is the fifth balloon to receive FDA approval, and its pivotal clinical trial results showed a 15% weight decrease and an 84% success rate. The balloon has been implanted in almost 100,000 patients in over 40 countries, and its unique adjustability feature has created an effective and safe weight loss therapy.
• In June 2023, Allurion signed a 12-month pilot collaboration agreement with Medtronic to distribute its swallowable gastric balloon and AI platform for weight loss. The balloon, which stays in place for about four months, is designed to curb hunger and fill up the stomach. Patients can monitor their progress and receive behavior-changing guidance using Allurion's connected scale, health-tracking smartwatch, and mobile app. The company believes this partnership will accelerate the adoption of the Iris AI platform as a standalone offering to streamline the management of patients undergoing bariatric surgery and potentially improve outcomes.
• In April 2023, Boston Scientific completed the acquisition of Apollo Endosurgery, valued at approximately US$ 615 Mn. Apollo Endosurgery's product portfolio includes devices used during endoluminal surgery (ELS) procedures, which are less-invasive alternatives to open and laparoscopic surgery. The acquisition is an exciting step forward in providing a more comprehensive suite of endoluminal surgery and endobariatric solutions.

Regions Covered:

North America(USA, Canada and Mexico)
Europe(UK, Germany, France and the Rest of Europe)
Asia Pacific(China, Japan, India, and the Rest of the Asia Pacific region)
South America(Brazil, Argentina and the Rest of South America)
Middle East and Africa(GCC and Rest of the Middle East and Africa)

Place an Order Copy of the Report: https://www.transparencymarketresearch.com/checkout.php?rep_id=26006&ltype=S&utm_source=organic&utm_campaign=MansiR_organic

Future Outlook:

The intragastric balloons market is poised for significant growth in the coming years, driven by technological advancements, increasing healthcare expenditure, and rising awareness about obesity-related health risks. Emerging economies present untapped opportunities for market players to expand their presence and address unmet needs.

Key Market Study Points:

• Assessment of market dynamics including drivers, challenges, and trends
• Analysis of market segmentation by service type, sourcing type, application, industry vertical, and region
• Evaluation of competitive landscape and key market players
• Examination of recent developments such as product launches, mergers, and acquisitions
• Forecasting market growth and opportunities for stakeholders

Browse More Reports by TMR:

Polypropylene Market to Rise at a CAGR of 5.7% during Forecast Period

Robotic Pool Cleaner Market to reach US$ 1.3 Bn by 2031

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact:

Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website:  https://www.transparencymarketresearch.com   
Email: sales@transparencymarketresearch.com
Follow Us: LinkedIn| Twitter| Blog | YouTube